New Delhi [India], April 15 (ANI): In view of the rapid surge in coronavirus cases in India, the Central government approved a significant streamlining and fast-tracking of the regulatory system for COVID-19 vaccines approved for restricted use by US FDA, EMA, UK MHRA, PMDA Japan or which ar
New Delhi [India], April 15 (ANI): The Central Government on Thursday issued the regulatory pathway in India for COVID-19 vaccines approved for restricted use by US FDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO Emergency Use Listing (EUL), said the Union Health Ministry.
New Delhi [India], April 13 (ANI): The Central government has fast-tracked emergency approvals for foreign-produced COVID-19 vaccines that have been granted Emergency Use Authorization (EUA) in other countries to expand the basket of vaccines for domestic use and hasten the pace and coverage